Benjamin et al 1 address the risk of atrial fibrillation (AF) in the Framingham Study with a longitudinal population design, which overcomes the common problem of selection bias. However, the study sample was predominantly white, and the one epidemiological question that remains unanswered is the relationship between race and the incidence of AF.
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We thank Drs Gibbs and Lip for their interest in our work. As acknowledged in the article, the generalizability of our finding of an association of atrial fibrillation and increased risk of death remains to be established in other racial and ethnic minorities. 1 Aside from the work cited by Drs Gibbs and Lip, there are few published studies of atrial fibrillation in nonwhite populations. The existing literature hints that there are racial and ethnic differences in the epidemiology of atrial fibrillation. However, ethnic and international comparisons of the prevalence of atrial fibrillation are hampered by differences in study design. For instance, a study of 984 Himalayan village residents in India found a prevalence of atrial fibrillation of only 0.1% (nϭ1). 2 However, the participants were healthy, received only a single ECG, and only 6% were Ͼ65 years of age. Racial differences in the prevalence of atrial fibrillation are also suggested by the Cardiovascular Health Study, a 4-community study of the elderly in the United States. Blacks constituted only 5% of the study sample, but the investigators noted that there was a trend for blacks to have a lower incidence of atrial fibrillation than whites (relative risk 0.47, 95% CI 0.22-1.01). 3 However, it is unclear whether or not these racial differences would have persisted if the analysis had been restricted to atrial fibrillation detected on routinely ascertained study ECGs.
There is a similar paucity of data regarding ethnic differences in the prognosis and treatment of atrial fibrillation. The Atrial Fibrillation Investigators noted that only 5% of patients enrolled in randomized controlled trials of warfarin were nonwhite; the investigators did not comment on racial differences in stroke rate. 4 In contrast, in a prospective study of ischemic stroke patients in northern Manhattan (35% black, 46% Hispanic, and 19% white), a history of atrial fibrillation was less prevalent in both blacks (11%) and Hispanics (11%) than among whites (29%; PϽ0.01 for black versus white and for Hispanic versus whites). However, the latter analysis was unadjusted. 5 In summary, we concur with Drs Gibbs and Lip that there is a regrettable lack of knowledge about the epidemiology, prognosis, and treatment of atrial fibrillation in ethnic minorities and for much of the developing world. 6 We hope these deficits will be rectified soon.
